Skip to main content
Back
finqOS
Search a stock, list or screen
⌘K
Not investment advice
Read full disclaimer
SABS
———
Overview
Company
Financials
Valuation
News
Ownership
Documents
SABS: SAB Biotherapeutics, Inc. Stock Analysis | finqOS
SABS
$2.81
−3.44%
Lists
Call SABS
SAB Biotherapeutics
SABS
Back
Lists
Call SABS
$2.81
−$0.10 · −3.44%
Closed
Overview
Company
Financials
Valuation
News
Ownership
Documents
Down
26%
in three months and
14%
of the way up its 52-week range.
Call SABS
Loading chart data...
Signal state